RE:zenith Hi regardless.
I do believe that at some point there will be liquidity, however, as I've posted before, I am extremely frustrated by Don's flippant statements.
A year ago he said there would be an IPO in Q4 2015 and he failed. At the update on Jan 7th he said there will be an IPO in 2016 through a reverse takeover of an already TSX or NASDAQ listed company.
Some have surmised that with the new structure of Zenith into ZEN Capital and ZEN Epigenetics there is the possibility of IPOs for each ZEN Epi drug such as ZEN 3694 if the prostate trial tuns out positive. If that trial shows early success it could sky rocket RVX shares and very quickly lead to a ZEN IPO (IMHO).
If this takes place I believe Zenith will be a gold mine of ongoing IPO's for various indications in cancer, CKD and many concerns re inflammation.
But Don said that Zeniith is a long term strategy (3 years). The 3 years coincides approximately when rvx-208 could start to generate revenue re CVD and DM.
If I live that long I will be a very happy investor with the various ZEN IPOs and the royalty revenues flowing into ZEN Capital.
So I am not much help to you on your question but I'm sure there are many extremely upset Zenith shareholders at this stage...I for one.
My opinion is that they seem to have highly talented scientists working on various projects. So it will be a matter of time.
Cheers
Toinv